Trial intelligence / Profile preview

Illuminate Cream for Melasma

NCT02730819Phase 2Completed

Sponsor
Mayo Clinic
Start
May 2016
Primary completion
Dec 2016
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Illuminate Cream in melasma, sponsored by Mayo Clinic. Started May 2016; status: completed.

02

Drugs

Illuminate Cream
03

Conditions

melasma

Beyond the preview

Go deeper on NCT02730819.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02730819.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call